S. Navaneethan

发表

Development and validation of an electronic health record-based chronic kidney disease registry.

S. Navaneethan, S. Jolly, J. Schold, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.

F. Kronenberg, M. Woodward, A. Garg, 2016, JAMA.

Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study.

Anna C. Porter, H. Feldman, R. Townsend, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Diet and CKD

S. Navaneethan, Holly J. Kramer, H. Kramer, 2019, Nephrology Self-Assessment Program.

Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: Findings from the chronic renal insufficiency cohort study: Adiposity and Inflammation

M. Joffe, M. Reilly, H. Feldman, 2014 .

Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the CRIC study

M. Joffe, M. Reilly, H. Feldman, 2014, Obesity.

Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: Evidence-based advances in monitoring and treatment.

K. Khunti, J. Chan, I. D. de Boer, 2020, Kidney international.

Pragmatic Clinical Trials in CKD: Opportunities and Challenges.

Miguel A. Vazquez, I. D. de Boer, S. Navaneethan, 2016, Journal of the American Society of Nephrology : JASN.

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium

F. Kronenberg, M. Woodward, A. Levey, 2019, British Medical Journal.

Long-term inter-platform reproducibility, bias, and linearity of commercial PDFF MRI methods for fat quantification: a multi-center, multi-vendor phantom study

N. Obuchowski, C. McKenzie, S. Navaneethan, 2021, European Radiology.

Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD.

Mahboob Rahman, C. McKenzie, H. Feldman, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association Between Type of Vascular Access Used in Hemodialysis Patients and Subsequent Kidney Transplant Outcomes

W. Winkelmayer, S. Navaneethan, M. Montez-Rath, 2019, Kidney medicine.

Pantoea Agglomerans: An Unusual Inciting Agent in Peritonitis

S. Navaneethan, J. Sloand, M. Ferrantino, 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Darbepoetin for the anaemia of chronic kidney disease.

J. Craig, S. Navaneethan, S. Palmer, 2014, The Cochrane database of systematic reviews.

Haemoglobin targets: we were wrong, time to move on

J. Craig, S. Navaneethan, G. Tognoni, 2007, The Lancet.

Aldosterone antagonists for preventing the progression of chronic kidney disease.

D. Bolignano, S. Navaneethan, S. Palmer, 2014, The Cochrane database of systematic reviews.

A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease

Sonal Singh, S. Navaneethan, Sarah Aloudat, 2008, BMC nephrology.

Referral to Nephrologists for Chronic Kidney Disease Care: Is Non-Diabetic Kidney Disease Ignored?

V. Jeevanantham, S. Navaneethan, S. Nigwekar, 2007, Nephron Clinical Practice.

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

David W. Johnson, J. Craig, V. Perkovic, 2008, BMJ : British Medical Journal.

Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease

M. Tonelli, J. Craig, S. Navaneethan, 2012, Annals of Internal Medicine.

Treatment options for managing obesity in chronic kidney disease

S. Navaneethan, Vishnu P. Parvathareddy, K. Ella, 2021, Current opinion in nephrology and hypertension.

Urinary Albumin Excretion, HMW Adiponectin, and Insulin Sensitivity in Type 2 Diabetic Patients Undergoing Bariatric Surgery

P. Schauer, S. Kashyap, S. Navaneethan, 2010, Obesity surgery.

Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis

M. Turakhia, N. Bansal, W. Winkelmayer, 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical events and patient-reported outcome measures during CKD progression: findings from the CRIC study.

A. Cheung, L. Appel, H. Feldman, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.

J. Craig, S. Navaneethan, G. Strippoli, 2006, The Cochrane database of systematic reviews.

Targeting Parathyroid Hormone Levels in Dialysis Patients

S. Navaneethan, G. Saab, E. Slatopolsky, 2014, Seminars in dialysis.

Interventions for lowering plasma homocysteine levels in kidney transplant recipients.

M. Jardine, V. Perkovic, A. Cass, 2015, The Cochrane database of systematic reviews.

Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults

S. Navaneethan, J. Kirwan, S. Malin, 2014, The Journal of Nutrition, Health & Aging.

Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD.

S. Navaneethan, S. Jolly, J. Schold, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials.

S. Navaneethan, J. Schold, M. Schreiber, 2011, Clinical journal of the American Society of Nephrology : CJASN.

How to design a randomized controlled trial

David W. Johnson, S. Navaneethan, S. Palmer, 2010, Nephrology.

Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP).

G. Bakris, A. Kshirsagar, Suying Li, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

How to conduct a randomized trial

David W. Johnson, S. Navaneethan, S. Palmer, 2010, Nephrology.

Outcomes of transient ischemic attack in maintenance dialysis patients and those with chronic kidney disease.

S. Navaneethan, F. Saeed, F. Nahab, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cardiovascular Disease in CKD

S. Navaneethan, H. Kramer, 2019, Nephrology Self-Assessment Program.

Marked Variation of the Association of ESRD Duration Before and After Wait Listing on Kidney Transplant Outcomes

S. Navaneethan, J. Schold, A. Sehgal, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A systematic review of barriers in access to renal transplantation among African Americans in the United States

Sonal Singh, S. Navaneethan, 2006, Clinical transplantation.

Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis.

S. Navaneethan, D. Bushinsky, J. Buysse, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Sexual dysfunction in women with ESRD requiring hemodialysis.

David W. Johnson, A. Santoro, J. Craig, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline

K. Khunti, J. Chan, I. D. de Boer, 2020, Annals of Internal Medicine.

Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease.

W. Winkelmayer, S. Virani, S. Navaneethan, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Association between intensity of statin therapy and mortality in persons with chronic kidney disease.

W. Winkelmayer, S. Virani, S. Navaneethan, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Outcomes of Infected Cardiovascular Implantable Devices in Dialysis Patients

S. Navaneethan, J. Schold, W. Tang, 2014, American Journal of Nephrology.

Treatment Options for Proliferative Lupus Nephritis

S. Navaneethan, G. Strippoli, G. Viswanathan, 2012, Drugs.

Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.

Francesca N. Delling, C. Callaway, E. Benjamin, 2021, Circulation.

Atherectomy for peripheral arterial disease

S. Navaneethan, G. Viswanathan, 2007 .

Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.

M. Wolf, Jiang He, M. Kretzler, 2017, Kidney international.

Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012.

Mahboob Rahman, W. Winkelmayer, S. Navaneethan, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease

S. Navaneethan, S. Arrigain, C. Fealy, 2015, American Journal of Nephrology.

Albuminuria: When urine predicts kidney and cardiovascular disease

S. Navaneethan, S. Jolly, J. Nally, 2014, Cleveland Clinic Journal of Medicine.

Obesity, Anthropometric Measures and Chronic Kidney Disease Complications

M. Sarnak, S. Navaneethan, J. Schold, 2012, American Journal of Nephrology.

Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.

David W. Johnson, P. Gao, J. Craig, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease

S. Navaneethan, J. Hegbrant, G. Strippoli, 2011, Current opinion in nephrology and hypertension.

Glomerular Filtration Rate Slopes Have Significantly Improved Among Renal Transplants in the United States

S. Navaneethan, J. Schold, T. Srinivas, 2010, Transplantation.

Timely referral alone may not be enough for patients with chronic kidney disease.

S. Navaneethan, S. Nigwekar, Sagar U. Nigwekar, 2007, Mayo Clinic proceedings.

Lack of permanent access in late referrals and its implications: not to be forgotten.

S. Navaneethan, S. Nigwekar, 2008, The American journal of medicine.

Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5.

W. Winkelmayer, Subhash Banerjee, S. Virani, 2021, Hypertension.

Presence and outcomes of kidney disease in patients with pulmonary hypertension.

Mahboob Rahman, R. Dweik, S. Navaneethan, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Trials and Tribulations in Studying Kidney Outcomes With Intentional Weight Loss

S. Navaneethan, 2019, Circulation.

Development and Validation of a Pragmatic Electronic Phenotype for CKD.

Jenna M. Norton, Kensaku Kawamoto, C. Jurkovitz, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Should Monitoring of Fibroblast Growth Factor‐23 Levels in Dialysis Patients Be a Part of Routine Clinical Practice?

S. Navaneethan, G. Saab, E. Slatopolsky, 2014, Seminars in dialysis.

Statins in Patients with Chronic Kidney Disease: Evidence from Systematic Reviews and Randomized Clinical Trials

S. Navaneethan, G. Strippoli, F. Pansini, 2006, PLoS medicine.

Early eGFR decline after SGLT2i initiation: knowns and unknowns.

S. Navaneethan, L. Gregg, 2021, Kidney international.

Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.

S. Mishra, W. Winkelmayer, C. Ballantyne, 2018, Clinical journal of the American Society of Nephrology : CJASN.

A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?

M. Gulati, G. Levine, S. Virani, 2022, Current Cardiology Reports.

Genetics

S. Navaneethan, Holly J. Kramer, 2019, Nephrology Self-Assessment Program.

Interventions for treating sexual dysfunction in patients with chronic kidney disease.

S. Navaneethan, E. Jannini, M. Ruospo, 2010, The Cochrane database of systematic reviews.

Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.

J. Craig, S. Navaneethan, S. Palmer, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

BP Targets in Older Adults with CKD: Additional Evidence, but Uncertainty Continues.

S. Navaneethan, A. Whaley-connell, A. Whaley-Connell, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex.

W. Zareba, J. Daubert, J. Bax, 2008, Cardiology journal.

Recurrent Pleural and Pericardial Effusions Due to Sarcoidosis

S. Navaneethan, R. Israel, R. Shrivastava, 2005, PLoS medicine.

Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.

J. Craig, S. Navaneethan, S. Palmer, 2011, The Cochrane database of systematic reviews.

Interventions for preventing thrombosis in adults and children with nephrotic syndrome

S. Navaneethan, M. Grieff, S. Kulshrestha, 2011 .

Atrial natriuretic peptide for preventing and treating acute kidney injury.

S. Navaneethan, C. Parikh, S. Nigwekar, 2009, The Cochrane database of systematic reviews.

Thyroxine for acute kidney injury

S. Navaneethan, G. Strippoli, S. Nigwekar, 2007 .

The landscape of renal replacement therapy in Veterans Affairs Medical Center intensive care units

W. Winkelmayer, S. Navaneethan, S. Crowley, 2020, Renal failure.

Patency and Complications of Translumbar Dialysis Catheters

S. Navaneethan, J. Schold, S. Arrigain, 2015, Seminars in dialysis.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

David W. Johnson, J. Craig, V. Perkovic, 2009, The Cochrane database of systematic reviews.

Thromboprophylaxis in cancer patients with central venous catheters

Sonal Singh, S. Navaneethan, Amit Nautiyal, 2007, Thrombosis and Haemostasis.

Moving Beyond Tools and Building Bridges: Lessons Learned From a CKD Decision Support in Primary Care

S. Navaneethan, M. Estrella, P. Joshi, 2022, Kidney medicine.

Statins for prevention of contrast‐induced nephropathy in patients undergoing non‐emergent percutaneous coronary intervention

S. Navaneethan, S. Markwell, R. Shah, 2010, Nephrology.

Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease

Connie M. Rhee, Keith C. Norris, S. Weisbord, 2017, Seminars in dialysis.

Are All SGLT2 Inhibitors Created Equal?

S. Navaneethan, L. Gregg, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Antimicrobial Agents and Catheter-Related Interventions to Prevent Peritonitis in Peritoneal Dialysis: Using Evidence in the Context of Clinical Practice

J. Craig, S. Navaneethan, G. Strippoli, 2006, The International journal of artificial organs.

Progress in the management of patients with diabetes and chronic kidney disease

S. Navaneethan, L. Pozo Garcia, Sandhya S. Thomas, 2022, Current opinion in nephrology and hypertension.

Black Race Coefficient in GFR Estimation and Diabetes Medications in CKD: National Estimates.

W. Winkelmayer, S. Navaneethan, C. Walther, 2021, Journal of the American Society of Nephrology : JASN.

Tacrolimus-associated hypomagnesemia in renal transplant recipients.

V. Jeevanantham, S. Navaneethan, S. Sankarasubbaiyan, 2006, Transplantation proceedings.

Bariatric surgery for obesity-associated decline in kidney function: filling the knowledge gap?

S. Navaneethan, V. Agrawal, 2016, Kidney international.

Therapeutic Options for Management of Diabetic Nephropathy

S. Navaneethan, Holly J. Kramer, H. Kramer, 2019, Nephrology Self-Assessment Program.

Diabetes and Kidney Disease: A Review of the Clinical Practice Guidelines

S. Navaneethan, Sehrish Ali, N. Aggarwal, 2022, Diabetes and Kidney Disease.

Sodium-glucose Co-transporter 2 Inhibitors and Blood Pressure Reduction among Patients with Diabetes, Cardiovascular Disease, Chronic Kidney Disease

S. Navaneethan, Addison A. Taylor, L. Gregg, 2021, Hypertension Journal.

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Mark E Molitch, Irl B Hirsch, Kamyar Kalantar-Zadeh, 2014, Diabetes Care.

Revisiting diuretic choice in chronic kidney disease

S. Virani, S. Navaneethan, Sehrish Ali, 2022, Current opinion in nephrology and hypertension.

Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs).

S. Virani, S. Navaneethan, D. Ramsey, 2022, The American journal of cardiology.

Diagnosis and Management of Pulmonary Hypertension in Patients With CKD.

S. Navaneethan, Vijay Nambi, N. Hanania, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Phosphate Binders: The Evidence Gap Persists.

W. Winkelmayer, S. Navaneethan, M. Airy, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study

W. Winkelmayer, Subhash Banerjee, S. Virani, 2022, Journal of Investigative Medicine.

Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996–2014)

W. Winkelmayer, S. Navaneethan, K. Erickson, 2018, American Journal of Nephrology.

Heart failure-type symptom scores in chronic kidney disease: The importance of body mass index

Julia S. Benoit, A. Go, Mahboob Rahman, 2022, International Journal of Obesity.

Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension.

W. Winkelmayer, S. Navaneethan, Vijay Nambi, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Elevated pulmonary pressure: A novel risk marker in kidney disease?

R. Dweik, S. Navaneethan, 2015, Kidney international.

Idiopathic Hypereosinophilic Syndrome: A Rare but Fatal Condition Presenting with Common Symptoms

S. Navaneethan, J. Fetten, A. Osowo, 2006, Southern medical journal.

Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials.

David W. Johnson, S. Navaneethan, E. Jannini, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Predicting Mortality after Severe Acute Kidney Injury: A Step Forward but Not Close to the Finish Line

S. Navaneethan, Shilpa Sharma, 2015, American Journal of Nephrology.

Distinctive kidney function trajectories following left ventricular assist device implantation.

Julia S. Benoit, S. Navaneethan, N. K. Mondal, 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

Rizwan Kalani, G. Roth, K. Yaffe, 2022, Circulation.

Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies.

David W. Johnson, J. Craig, S. Navaneethan, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Management of cardiovascular risk factors and other comorbidities in chronic kidney disease.

S. Navaneethan, M. Ajmal, Sehrish Ali, 2020, Current opinion in nephrology and hypertension.

Heart failure-type symptom scores in chronic kidney disease: The importance of body mass index

Julia S. Benoit, A. Go, Mahboob Rahman, 2022, International Journal of Obesity.

Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD.

W. Winkelmayer, S. Navaneethan, A. Deswal, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Updated US Prevalence Estimates for Chronic Kidney Disease Stage and Complications Using the New Race-Free Equation to Estimate Glomerular Filtration Rate

W. Winkelmayer, S. Navaneethan, C. Walther, 2022, JAMA network open.

nCorrelates of SGLT-2-inhibitiors Use Among Patients with Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus: Insights from the Department of Veterans Affairs.

S. Virani, S. Navaneethan, L. Petersen, 2021, American heart journal.

Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study

A. Go, Mahboob Rahman, S. Kasner, 2022, Kidney medicine.

Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis.

W. Winkelmayer, W. Mitch, S. Navaneethan, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.

M. Matheny, C. Ballantyne, C. Lavie, 2022, Diabetes care.

Classification of Pulmonary Hypertension in CKD.

S. Navaneethan, A. Deswal, Jingyin Yan, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Deepak L. Bhatt, P. Schauer, S. Kashyap, 2014, The New England journal of medicine.

Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study.

P. Schauer, S. Kashyap, S. Navaneethan, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

K. Khunti, I. D. de Boer, C. Wanner, 2022, Kidney international.

Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence.

K. Khunti, I. D. de Boer, M. Tonelli, 2022, Kidney international.

Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids.

W. Winkelmayer, S. Navaneethan, A. Naik, 2020, Journal of the American Society of Nephrology : JASN.

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5‐Year Outcomes

Deepak L. Bhatt, Rishi P. Singh, P. Schauer, 2017, The New England journal of medicine.

Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study.

David W. Johnson, A. Santoro, J. Craig, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

HDL-cholesterol and causes of death in chronic kidney disease

S. Virani, S. Navaneethan, S. Jolly, 2018 .

Direct renin inhibitors for preventing the progression of diabetic kidney disease

H. Bang, A. Kshirsagar, S. Navaneethan, 2013, Cochrane Database of Systematic Reviews.

Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease.

S. Navaneethan, C. Walther, 2017, Journal of the American Society of Nephrology : JASN.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

David W. Johnson, J. Craig, V. Perkovic, 2014, The Cochrane database of systematic reviews.

Incidence and predictors of nonalcoholic fatty liver disease among patients with chronic kidney disease.

S. Navaneethan, Peter A. Richardson, L. Gregg, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease

S. Navaneethan, C. Fealy, Hazel Huang, 2020, Obesity science & practice.

Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation.

Burr Hall, Abrar H. Shah, J. Daubert, 2010, The American journal of cardiology.

Emerging therapeutic options for management of anaemia in with patients with chronic kidney disease.

S. Navaneethan, Sehrish Ali, Natasha N. Dave, 2018, Current opinion in nephrology and hypertension.

Emerging therapeutic options for managing diabetic kidney disease.

S. Navaneethan, A. Whaley-connell, C. Walther, 2017, Current opinion in nephrology and hypertension.

Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol

S. Jassal, M. Shlipak, M. Goldstein, 2022, BMC Nephrology.

Heart Failure-Type Symptom Score Trajectories in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Julia S. Benoit, N. Bansal, S. Navaneethan, 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Editorial

S. Navaneethan, A. Shah, 2019, Current Opinion in Nephrology and Hypertension.

Novel therapeutic options for management of electrolyte disorders.

S. Navaneethan, A. Shah, 2019, Current opinion in nephrology and hypertension.

Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis

S. Navaneethan, A. Sehgal, M. Dobre, 2011, International Urology and Nephrology.

Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.

S. Navaneethan, G. Strippoli, G. Viswanathan, 2008, Drugs.

HMG CoA reductase inhibitors (statins) for dialysis patients.

David W. Johnson, J. Craig, V. Perkovic, 2009, The Cochrane database of systematic reviews.

Aldosterone antagonists for preventing the progression of chronic kidney disease.

S. Navaneethan, G. Strippoli, A. Sehgal, 2009, The Cochrane database of systematic reviews.

Rituximab treatment of fibrillary glomerulonephritis.

B. Rovin, S. Navaneethan, G. Appel, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Contents Vol. 9, 2019

Connie M. Rhee, D. Lackland, B. Falkner, 2019, CardioRenal Medicine.

Dysnatremias, Mortality, and Kidney Failure in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study

S. Navaneethan, J. Schold, S. Arrigain, 2022, Kidney medicine.

Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients.

V. Jeevanantham, S. Navaneethan, J. Nally, 2010, Clinical nephrology.

Thyroid hormones for acute kidney injury.

S. Navaneethan, G. Strippoli, S. Nigwekar, 2013, The Cochrane database of systematic reviews.

Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort.

S. Virani, S. Navaneethan, M. Matheny, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Sonal Singh, S. Navaneethan, A. Sehgal, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

I. D. de Boer, G. Bakris, I. Hirsch, 2014, Diabetes Care.

Diabetic Kidney Disease: A Report From an ADA Consensus

G. Bakris, I. Hirsch, K. Kalantar-Zadeh, 2014 .

A Whole-Grain Diet Reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial.

S. Navaneethan, J. Kirwan, A. Ross, 2016, The Journal of nutrition.

An overlooked differential diagnosis of acute chest pain.

S. Navaneethan, G. Viswanathan, 2007, Southern medical journal.

Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder

S. Navaneethan, M. Schreiber, S. Palmer, 2009, Nephrology.

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis

M. Jardine, V. Perkovic, A. Cass, 2012, BMJ : British Medical Journal.

Lifestyle-induced decrease in fat mass improves adiponectin secretion in obese adults.

S. Navaneethan, K. Kelly, J. Kirwan, 2014, Medicine and science in sports and exercise.

Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease

S. Virani, S. Navaneethan, Sehrish Ali, 2019, Current Atherosclerosis Reports.

Interventions for lowering plasma homocysteine levels in dialysis patients.

M. Jardine, V. Perkovic, A. Cass, 2016, The Cochrane database of systematic reviews.

Possible cocaine-induced acute renal failure without rhabdomyolysis.

Sonal Singh, S. Navaneethan, M. Rivero, 2006, Journal of nephrology.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

David W. Johnson, J. Craig, V. Perkovic, 2014, The Cochrane database of systematic reviews.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

David W. Johnson, J. Craig, V. Perkovic, 2009, The Cochrane database of systematic reviews.

Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations.

S. Navaneethan, G. Francis, Srisakul Chirakarnjanakorn, 2017, International journal of cardiology.

Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.

Mahboob Rahman, J. Coresh, L. Appel, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease

S. Navaneethan, S. Jolly, J. Schold, 2015, American Journal of Nephrology.

Associations of dysnatremias with mortality in chronic kidney disease

S. Navaneethan, S. Jolly, J. Schold, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

A. Go, Mahboob Rahman, L. Appel, 2018, Journal of the American Society of Nephrology : JASN.

KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

K. Khunti, J. Chan, N. Tandon, 2020, Kidney international.

Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population.

S. Navaneethan, J. Schold, S. Arrigain, 2013, American Journal of Kidney Diseases.

Statin use and hip fractures in U.S. kidney transplant recipients

W. Winkelmayer, S. Navaneethan, M. Montez-Rath, 2017, BMC Nephrology.

World-Wide Long-Term (20–40 Years) Renal Transplant Outcomes and Classification of Long-Term Patient and Allograft Survivals

S. Navaneethan, W. Braun, D. Protiva, 2011 .

Metabolic syndrome and kidney disease: a systematic review and meta-analysis.

S. Kashyap, S. Navaneethan, J. Kirwan, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Bariatric surgery and progression of chronic kidney disease.

S. Navaneethan, Hans Yehnert, 2009, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis.

P. Schauer, S. Navaneethan, M. Schreiber, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Integrative Approach in Chronic Kidney Disease

S. Navaneethan, Samaya J Anumudu, A. Awan, 2020 .

Nonesterified Fatty Acids and Kidney Function Decline in Older Adults: Findings From the Cardiovascular Health Study.

L. Djoussé, S. Navaneethan, J. Ix, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease

David W. Johnson, A. Garg, M. Tonelli, 2010, Annals of Internal Medicine.

GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.

G. Beck, J. Coresh, H. Tighiouart, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Metabolic syndrome, ESRD, and death in CKD.

S. Navaneethan, S. Jolly, J. Schold, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Mahboob Rahman, M. Wolf, L. Appel, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.

A. Go, Mahboob Rahman, M. Wolf, 2016, JAMA cardiology.

CKD Progression

S. Navaneethan, Holly J. Kramer, 2019, Nephrology Self-Assessment Program.

CKD Epidemiology

S. Navaneethan, Holly J. Kramer, 2019, Nephrology Self-Assessment Program.

Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.

M. Woodward, A. Köttgen, J. Coresh, 2018, Kidney international.

Association of antibiotic use and acute kidney injury in patients hospitalized with community-acquired pneumonia

S. Navaneethan, M. Rothberg, P. Imrey, 2021, Current medical research and opinion.

Management of type 2 diabetes in chronic kidney disease

S. Virani, S. Navaneethan, Jefferson L Triozzi, 2021, BMJ Open Diabetes Research & Care.

Serum testosterone levels and mortality in men with CKD stages 3-4.

S. Navaneethan, J. Schold, S. Arrigain, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

S. Navaneethan, G. Strippoli, A. Sehgal, 2009, Clinical journal of the American Society of Nephrology : CJASN.

IgA-dominant Staphylococcus infection-associated glomerulonephritis: case reports and review of the literature

S. Navaneethan, J. Simon, M. Pohl, 2011, NDT plus.

Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease.

S. Navaneethan, S. Jolly, J. Schold, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality.

C. McCulloch, A. Go, H. Feldman, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Preemptive renal transplant candidate survival, access to care, and renal function at listing.

S. Navaneethan, J. Schold, J. Nally, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease.

M. Sarnak, S. Navaneethan, S. Jolly, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers?

S. Navaneethan, E. Bravo, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial.

S. Navaneethan, D. Hricik, J. Albert, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Metabolic syndrome and mild to moderate chronic kidney disease among minorities.

S. Navaneethan, J. Schold, T. Srinivas, 2010, Seminars in nephrology.

Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization

W. Winkelmayer, S. Navaneethan, A. Deswal, 2020, American Journal of Nephrology.

Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.

J. Craig, S. Navaneethan, S. Palmer, 2006, The Cochrane database of systematic reviews.

Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Rasheeda K. Hall, M. Zhan, C. Diamantidis, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Baroreflex stimulation: A novel treatment option for resistant hypertension.

T. Lohmeier, S. Navaneethan, J. Bisognano, 2009, Journal of the American Society of Hypertension : JASH.

Patients as stakeholders in setting kidney disease research priorities.

S. Navaneethan, J. Sedor, L. Boulware, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Estimated GFR Decline and Tubular Injury Biomarkers With Intensive Blood Pressure Control.

S. Navaneethan, C. Walther, Maulin K Shah, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis.

Daniel A. London, S. Kashyap, S. Navaneethan, 2016, Journal of diabetes and its complications.

Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Sadeer G. Al-Kindi, A. Go, Mahboob Rahman, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.

W. Winkelmayer, S. Navaneethan, Peter A. Richardson, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.

Mahboob Rahman, J. Roy, R. Townsend, 2016, Journal of the American Society of Nephrology : JASN.

Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease

S. Navaneethan, S. Mandayam, 2017, Kidney international reports.

Bariatric Surgery and Kidney-Related Outcomes

S. Navaneethan, M. Grams, Alex R. Chang, 2017, Kidney international reports.

Body mass index and causes of death in chronic kidney disease.

S. Navaneethan, J. Schold, S. Arrigain, 2016, Kidney international.

Facility‐level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database

S. Virani, S. Navaneethan, L. Petersen, 2017, Clinical Cardiology.

Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up.

P. Schauer, H. Heneghan, D. Cetin, 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.

D. Bolignano, S. Navaneethan, M. Ruospo, 2020, The Cochrane database of systematic reviews.

Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006

S. Navaneethan, J. Schold, S. Arrigain, 2012, International Journal of Obesity.

Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients

J. Healey, S. Navaneethan, Douglas S. Lee, 2018, Journal of Interventional Cardiac Electrophysiology.

Omega‐3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk

S. Virani, S. Navaneethan, 2017, Journal of the American Heart Association.

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

Rizwan Kalani, K. Yaffe, M. Mussolino, 2023, Circulation.

Electronic health records: a new tool to combat chronic kidney disease?

Anil Jain, Jesse D. Schold, S. Navaneethan, 2013, Clinical nephrology.

Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999–2004

S. Navaneethan, J. Schold, S. Arrigain, 2014, BMC Nephrology.

HMG CoA reductase inhibitors (statins) for dialysis patients.

David W. Johnson, J. Craig, V. Perkovic, 2009, The Cochrane database of systematic reviews.

How to read a nephrology systematic review

S. Navaneethan, S. Palmer, G. Strippoli, 2010, Nephrology.

High-density lipoprotein cholesterol and causes of death in chronic kidney disease.

W. Winkelmayer, S. Virani, S. Navaneethan, 2018, Journal of clinical lipidology.

Nontraumatic Subarachnoid Hemorrhage in Maintenance Dialysis Hospitalizations: Trends and Outcomes

S. Navaneethan, J. Schold, G. Kumar, 2014, Stroke.

Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study

N. Powe, A. Wu, P. Ephraim, 2012, BMC Nephrology.

Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis.

S. Navaneethan, C. Parikh, S. Nigwekar, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Fibroblast growth factor 23 and Inflammation in CKD.

Huiliang Xie, M. Wolf, M. Kretzler, 2012, American Society of Nephrology. Clinical Journal.

Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.

B. Wilkoff, S. Navaneethan, S. Jolly, 2015, American Society of Nephrology. Clinical Journal.

Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD.

M. Turakhia, W. Winkelmayer, S. Navaneethan, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

2009 Influenza A Infection and Acute Kidney Injury: Incidence, Risk Factors, and Complications

S. Navaneethan, R. Raina, S. Gordon, 2011, American Journal of Nephrology.

CKD and Other Comorbidities

S. Navaneethan, H. Kramer, 2019, Nephrology Self-Assessment Program.

Cause-Specific Deaths in Non-Dialysis-Dependent CKD.

S. Navaneethan, S. Jolly, J. Schold, 2015, Journal of the American Society of Nephrology : JASN.

HMG CoA reductase inhibitors (statins) for dialysis patients.

David W. Johnson, J. Craig, V. Perkovic, 2009, The Cochrane database of systematic reviews.

Association of Metabolic Syndrome With Kidney Function and Histology in Living Kidney Donors

A. Rule, S. Navaneethan, J. Schold, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD.

S. Navaneethan, S. Jolly, J. Schold, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD.

Mahboob Rahman, K. Yaffe, H. Feldman, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Implantable Ventricular Assist Device Use and Outcomes in People With End‐Stage Renal Disease

W. Winkelmayer, S. Navaneethan, J. Morgan, 2018, Journal of the American Heart Association.

Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.

M. Zhan, E. Soliman, P. Delafontaine, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update

K. Khunti, I. D. de Boer, M. Tonelli, 2023, Annals of Internal Medicine.

Nephrology Considerations in the Management of Durable and Temporary Mechanical Circulatory Support

S. Navaneethan, A. Civitello, K. Liao, 2022, Kidney360.

Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice.

C. Wanner, D. Wheeler, N. Desai, 2023, Journal of diabetes and its complications.

Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey.

C. Ballantyne, S. Virani, S. Navaneethan, 2021, Population health management.

Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD.

W. Winkelmayer, S. Navaneethan, S. Jolly, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease

M. Desai, B. Griffin, S. Navaneethan, 2019, Journal of the American Heart Association.

Safety analysis of primary bariatric surgery in patients on chronic dialysis

P. Schauer, A. Aminian, Amin Andalib, 2016, Surgical Endoscopy.

An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease

L. N. Valenti, H. Tilg, V. Wong, 2023, Hepatobiliary surgery and nutrition.

Research-based versus clinical serum creatinine measurements and the association of acute kidney injury with subsequent kidney function: findings from the Chronic Renal Insufficiency Cohort study

Anna C. Porter, C. McCulloch, A. Go, 2019, Clinical Kidney Journal.

Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings.

A. Go, Mahboob Rahman, L. Appel, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Development of a chronic kidney disease patient navigator program

S. Navaneethan, S. Jolly, J. Schold, 2015, BMC Nephrology.

Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis.

W. Winkelmayer, S. Navaneethan, M. Montez-Rath, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease.

S. Navaneethan, S. Beddhu, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Chronic Kidney Disease in an Electronic Health Record Problem List: Quality of Care, ESRD, and Mortality

Jesse D. Schold, S. Navaneethan, S. Jolly, 2014, American Journal of Nephrology.

Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation

N. Bansal, W. Winkelmayer, S. Navaneethan, 2018, American Journal of Nephrology.

Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.

A. Wu, P. Ephraim, N. Tangri, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry

S. Navaneethan, J. Schold, S. Arrigain, 2018, Nephron.

Evidence for optimal hemoglobin targets in chronic kidney disease.

S. Navaneethan, F. Schena, G. Strippoli, 2006, JN. Journal of Nephrology (Milano. 1992).

Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease

R. Dweik, S. Navaneethan, S. Jolly, 2016, American Journal of Nephrology.

Physiological Age by Artificial Intelligence–Enhanced Electrocardiograms as a Novel Risk Factor of Mortality in Kidney Transplant Candidates

A. Rule, W. Kremers, N. LeBrasseur, 2023, Transplantation.

Impact of Uric Acid Levels on Kidney Disease Progression

S. Navaneethan, S. Jolly, J. Schold, 2017, American Journal of Nephrology.

Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs.

B. Bozkurt, C. Ballantyne, S. Virani, 2023, JACC. Heart failure.

Blood Pressure Parameters and their Associations with Death in Patients with Chronic Kidney Disease

S. Navaneethan, S. Qureshi, R. Lorch, 2017, Current Hypertension Reports.

Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease

S. Navaneethan, C. Walther, A. Chandra, 2018, Current opinion in nephrology and hypertension.

Front & Back Matter

C. Ronco, S. Navaneethan, J. Sowers, 2019, Cardiorenal Medicine.

Implications of the CKD-EPI GFR estimation equation in clinical practice.

S. Navaneethan, S. Jolly, J. Schold, 2011, Clinical journal of the American Society of Nephrology : CJASN.

TV Watching, but Not Physical Activity, Is Associated With Change in Kidney Function in Older Adults.

K. Patel, A. Newman, E. Simonsick, 2015, Journal of physical activity & health.

Cardiac resynchronization therapy in CKD: a systematic review.

G. Thomas, S. Navaneethan, J. Nally, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Dietary Patterns and Risk of Chronic Kidney Disease Progression and All-Cause Mortality: Findings from the CRIC study

Mahboob Rahman, J. Coresh, L. Appel, 2020, Current Developments in Nutrition.

Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.

W. Winkelmayer, S. Navaneethan, S. Jolly, 2017, Kidney international.

Bariatric Surgery for ESKD Patients: Why, When, and How?

S. Navaneethan, K. Erickson, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Bariatric Surgery for ESKD Patients

S. Navaneethan, K. Erickson, 2019 .

Renal Resistive Index and Mortality in Chronic Kidney Disease

S. Navaneethan, J. Schold, S. Arrigain, 2015, Hypertension.

Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study.

A. Go, Mahboob Rahman, M. Keane, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Obesity, Weight Loss, and Bariatric Surgery in Kidney Disease

S. Navaneethan, H. Kramer, 2019, Nephrology Self-Assessment Program.

Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes

A. Cheung, C. Yuan, M. Conroy, 2021, BMC Nephrology.

Social Support in Older Adults With CKD: A Report From the CRIC (Chronic Renal Insufficiency Cohort) Study

Anna C. Porter, Mahboob Rahman, J. Kusek, 2021, Kidney medicine.

Concomitant Intracranial Aneurysm and Carotid Artery Stenosis: A Therapeutic Dilemma

Rakesh Shrivastava, Sonal Singh, S. Navaneethan, 2006, Southern medical journal.

Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis

S. Navaneethan, S. Jolly, J. Schold, 2018, Nephron.

Novel Methodology and Tools to Improve Chronic Kidney Disease Care Measures

S. Navaneethan, H. Kramer, 2019, Nephrology Self-Assessment Program.

Outcomes of patients receiving maintenance dialysis admitted over weekends.

S. Navaneethan, J. Schold, G. Kumar, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

CKD Complications

S. Navaneethan, Holly J. Kramer, 2019, Nephrology Self-Assessment Program.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

David W. Johnson, J. Craig, V. Perkovic, 2014, The Cochrane database of systematic reviews.

Should Monitoring of Fibroblast Growth Factor‐23 Levels in Dialysis Patients Be a Part of Routine Clinical Practice?

S. Navaneethan, G. Saab, E. Slatopolsky, 2014, Seminars in dialysis.

Interventions for lowering plasma homocysteine levels in dialysis patients.

M. Jardine, V. Perkovic, A. Cass, 2016, The Cochrane database of systematic reviews.

HMG CoA reductase inhibitors (statins) for dialysis patients.

David W. Johnson, J. Craig, V. Perkovic, 2013, The Cochrane database of systematic reviews.

Pseudo-anion gap acidosis

S. Navaneethan, J. Sloand, R. Mooney, 2008, NDT plus.

Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients

J. Healey, S. Navaneethan, Douglas S. Lee, 2018, Journal of Interventional Cardiac Electrophysiology.

Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.

J. Craig, S. Navaneethan, S. Palmer, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

BMC Nephrology BioMed Central

Sonal Singh, S. Navaneethan, Sarah Aloudat, 2007 .

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.

F. Kronenberg, M. Woodward, A. Garg, 2016, JAMA.

Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.

M. Woodward, A. Köttgen, O. Djurdjev, 2018, Kidney international.

Atrial natriuretic peptide for preventing and treating acute kidney injury.

S. Navaneethan, C. Parikh, J. Hix, 2009, The Cochrane database of systematic reviews.

Urinary Albumin Excretion, HMW Adiponectin, and Insulin Sensitivity in Type 2 Diabetic Patients Undergoing Bariatric Surgery

P. Schauer, S. Kashyap, S. Navaneethan, 2010, Obesity surgery.

Bariatric surgery and progression of chronic kidney disease.

S. Navaneethan, Hans Yehnert, 2009, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Fibroblast growth factor 23 and Inflammation in CKD.

Huiliang Xie, M. Kretzler, S. Navaneethan, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis.

S. Navaneethan, C. Parikh, J. Hix, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Safety Issues with CKD

S. Navaneethan, H. Kramer, 2019, Nephrology Self-Assessment Program.

Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.

W. Winkelmayer, S. Navaneethan, S. Jolly, 2017, Kidney international.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

V. Perkovic, S. Navaneethan, S. Palmer, 2014, The Cochrane database of systematic reviews.

Renin–angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease

W. Winkelmayer, S. Virani, S. Navaneethan, 2021 .

Presence and outcomes of kidney disease in patients with pulmonary hypertension.

Mahboob Rahman, R. Dweik, S. Navaneethan, 2014, Clinical journal of the American Society of Nephrology : CJASN.

META‐ANALYSIS OF MYCOPHENOLATE MOFETIL IN IgA NEPHROPATHY

S. Navaneethan, G. Strippoli, G. Viswanathan, 2008, Nephrology.

Title Diabetic kidney disease : a report from an ADA Consensus Conference

G. Bakris, I. Hirsch, K. Kalantar-Zadeh, 2014 .

Erratum: Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR.

M. Landray, F. Kronenberg, B. Brenner, 2018 .

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

David W. Johnson, J. Craig, V. Perkovic, 2009, The Cochrane database of systematic reviews.

Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease

M. Tonelli, J. Craig, S. Navaneethan, 2012, Annals of Internal Medicine.

Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD.

M. Matheny, S. Virani, S. Navaneethan, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation.

Abrar H. Shah, J. Daubert, W. Hundley, 2010, The American journal of cardiology.

Diabetic kidney disease: a report from an ADA Consensus Conference.

S. Navaneethan, A. Narva, M. Molitch, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Antihypertensive Agents in Patients With Diabetes

S. Navaneethan, G. Strippoli, M. Querques, 2006, The Diabetes educator.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

V. Perkovic, S. Navaneethan, S. Palmer, 2014, Cochrane Database of Systematic Reviews.

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Rizwan Kalani, M. Mussolino, K. Evenson, 2024, Circulation.

Adherence to Plant-Based Diets and Risk of CKD Progression and All-Cause Mortality: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

S. Navaneethan, A. Ricardo, C. Rebholz, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Nodular glomerulosclerosis in a non-diabetic patient: case report and review of literature.

Sonal Singh, S. Navaneethan, Wajid M. Choudhry, 2005, Journal of nephrology.

Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes.

W. Winkelmayer, S. Navaneethan, J. Morgan, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Editorial: Advancements in the management of kidney disease and electrolyte derangements.

S. Navaneethan, Mike Holliday, 2022, Current opinion in nephrology and hypertension.

Implications of the CKD-EPI GFR estimation equation in clinical practice.

S. Navaneethan, S. Jolly, J. Schold, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease.

S. Navaneethan, S. Beddhu, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

METABOLIC SYNDROME AND CHRONIC KIDNEY DISEASE

S. Navaneethan, 2014 .

Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression

S. Navaneethan, Michael W Holliday, Livia Frost, 2024, Current opinion in nephrology and hypertension.